2024 Q3 Form 10-Q Financial Statement

#000100528624000110 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3 2023 Q2
Revenue $24.71M $24.52M $31.55M
YoY Change 0.75% -43.44% -33.77%
Cost Of Revenue $19.32M $21.79M $23.16M
YoY Change -11.36% -41.94% -36.22%
Gross Profit $5.387M $2.728M $8.391M
YoY Change 97.47% -53.14% -30.72%
Gross Profit Margin 21.81% 11.12% 26.6%
Selling, General & Admin $14.79M $9.206M $11.69M
YoY Change 60.6% -15.41% -38.23%
% of Gross Profit 274.46% 337.46% 139.27%
Research & Development $2.186M $2.146M $2.116M
YoY Change 1.86% 4.79% 2.92%
% of Gross Profit 40.58% 78.67% 25.22%
Depreciation & Amortization $1.993M $2.168M $3.118M
YoY Change -8.07% -56.72% -8.19%
% of Gross Profit 37.0% 79.47% 37.16%
Operating Expenses $16.97M $11.34M $13.80M
YoY Change 49.63% -18.86% -34.2%
Operating Profit -$11.58M -$8.614M -$5.411M
YoY Change 34.48% 5.6% -38.96%
Interest Expense -$5.368M -$3.938M -$4.454M
YoY Change 36.31% -207.07% 28.54%
% of Operating Profit
Other Income/Expense, Net -$203.0K -$170.0K -$318.0K
YoY Change 19.41% -5.56% -105.47%
Pretax Income -$16.26M -$12.52M -$33.57M
YoY Change 29.81% 4.35% -8.26%
Income Tax -$25.00K $88.20K $223.0K
% Of Pretax Income
Net Earnings -$16.23M -$10.75M -$36.13M
YoY Change 50.92% -10.86% -1.45%
Net Earnings / Revenue -65.7% -43.85% -114.53%
Basic Earnings Per Share -$0.53 -$0.35 -$1.32
Diluted Earnings Per Share -$0.53 -$0.35 -$1.19
COMMON SHARES
Basic Shares Outstanding 30.87M shares 30.40M shares 30.32M shares
Diluted Shares Outstanding 30.86M shares 30.40M shares

Balance Sheet

Concept 2024 Q3 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.520M $8.642M $19.09M
YoY Change -36.13% 104.69% 1061.96%
Cash & Equivalents $5.520M $8.642M $19.09M
Short-Term Investments
Other Short-Term Assets $1.876M $5.865M $5.078M
YoY Change -68.01% -18.05% -27.99%
Inventory $41.64M $41.69M $45.38M
Prepaid Expenses
Receivables $25.15M $26.62M $29.71M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $74.18M $82.81M $99.26M
YoY Change -10.42% -28.97% -19.76%
LONG-TERM ASSETS
Property, Plant & Equipment $148.8M $136.3M $134.6M
YoY Change 9.17% 5.61% 3.22%
Goodwill $13.88M $13.88M $13.90M
YoY Change 0.0% 0.0% 0.14%
Intangibles $4.200M $4.200M $4.200M
YoY Change 0.0% -50.0% -50.0%
Long-Term Investments
YoY Change
Other Assets $3.431M $4.307M $3.215M
YoY Change -20.34% 54.21% 7.1%
Total Long-Term Assets $172.6M $162.8M $155.9M
YoY Change 6.04% -3.78% -9.08%
TOTAL ASSETS
Total Short-Term Assets $74.18M $82.81M $99.26M
Total Long-Term Assets $172.6M $162.8M $155.9M
Total Assets $246.8M $245.6M $255.2M
YoY Change 0.49% -14.06% -13.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.01M $15.69M $22.14M
YoY Change 14.78% -4.12% 40.13%
Accrued Expenses $21.09M $10.59M $12.09M
YoY Change 99.06% -44.9% -35.09%
Deferred Revenue $8.300M $4.100M
YoY Change 933.62% 346.14%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $773.0K $773.0K $488.0K
YoY Change 0.0% -71.41% -18.53%
Total Short-Term Liabilities $40.52M $35.41M $38.78M
YoY Change 14.43% -57.38% -51.06%
LONG-TERM LIABILITIES
Long-Term Debt $105.5M $88.06M $101.3M
YoY Change 19.86% -8.14% 3.79%
Other Long-Term Liabilities $5.114M $219.0K $77.32M
YoY Change 2235.16% 10.05% 40596.32%
Total Long-Term Liabilities $110.7M $88.28M $178.6M
YoY Change 25.36% -8.11% 82.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.52M $35.41M $38.78M
Total Long-Term Liabilities $110.7M $88.28M $178.6M
Total Liabilities $207.3M $219.1M $217.7M
YoY Change -5.36% 15.97% 16.31%
SHAREHOLDERS EQUITY
Retained Earnings -$182.8M -$189.3M -$178.5M
YoY Change -3.45% 166.93% 203.37%
Common Stock $31.00K $30.00K $30.00K
YoY Change 3.33% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.938M -$13.56M $37.40M
YoY Change
Total Liabilities & Shareholders Equity $246.8M $245.6M $255.2M
YoY Change 0.49% -14.06% -13.56%

Cashflow Statement

Concept 2024 Q3 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$16.23M -$10.75M -$36.13M
YoY Change 50.92% -10.86% -1.45%
Depreciation, Depletion And Amortization $1.993M $2.168M $3.118M
YoY Change -8.07% -56.72% -8.19%
Cash From Operating Activities -$643.0K -$8.329M -$17.29M
YoY Change -92.28% 443.31% -48122.22%
INVESTING ACTIVITIES
Capital Expenditures $3.392M $5.054M $8.443M
YoY Change -32.88% 72.55% -187.99%
Acquisitions
YoY Change
Other Investing Activities $0.00 $940.0K
YoY Change -100.0% -109.6%
Cash From Investing Activities -$3.392M -$5.054M -$7.503M
YoY Change -32.88% -2553.4% -61.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities $1.093M $2.934M 40.93M
YoY Change -62.75% -24.88% 113.82%
NET CHANGE
Cash From Operating Activities -$643.0K -$8.329M -17.29M
Cash From Investing Activities -$3.392M -$5.054M -7.503M
Cash From Financing Activities $1.093M $2.934M 40.93M
Net Change In Cash -$2.942M -$10.45M 16.14M
YoY Change -71.84% -505.16% -7748.34%
FREE CASH FLOW
Cash From Operating Activities -$643.0K -$8.329M -$17.29M
Capital Expenditures $3.392M $5.054M $8.443M
Free Cash Flow -$4.035M -$13.38M -$25.73M
YoY Change -69.85% 199.93% -367.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
39000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
39000 shares
CY2023Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2108000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-10000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
1047000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11342000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9253000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8614000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3274000 usd
CY2022Q3 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
0 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
200000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-170000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-198000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12522000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6703000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12610000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6707000 usd
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
1850000 usd
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-4259000 usd
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-6000 usd
CY2022Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1856000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4259000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10754000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.41
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.41
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.23
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.23
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.06
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.06
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.14
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.14
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30403000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30403000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29577000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29577000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10754000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
16000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
300000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10754000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10666000 usd
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
39000 shares
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
39318000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4230000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
724000 usd
CY2023Q3 lfcr Temporary Equity Accretion Of Dividends Shares
TemporaryEquityAccretionOfDividendsShares
1000 shares
CY2023Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
748000 usd
CY2023Q3 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
748000 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
48000 usd
CY2023Q3 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
48000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1541000 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
40000 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
40114000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-13560000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
87823000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
67000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
785000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
300000 usd
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
77875000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10754000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2168000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4354000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1533000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
785000 usd
CY2023Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
76000 usd
CY2022Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-17000 usd
CY2023Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
3025000 usd
CY2022Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
200000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
21000 usd
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2108000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
18000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
849000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2587000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2426000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
739000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4202000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
581000 usd
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
371000 usd
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2865000 usd
CY2023Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2530000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
183000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8329000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1101000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5054000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3361000 usd
CY2023Q3 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2022Q3 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
3135000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5054000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
724000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27000 usd
CY2023Q3 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2281000 usd
CY2022Q3 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4000000 usd
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
45000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
67000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
26000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2934000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3906000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10449000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2579000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19091000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1643000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8642000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4222000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4741000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2243000 usd
CY2023Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
969000 usd
CY2022Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
513000 usd
CY2023Q3 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
748000 usd
CY2023Q3 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year is the 52- or 53-week period that ends on the last Sunday of May with quarters within each year ending on the last Sunday of August, November, and February; however, in instances where the last Sunday would result in a quarter being 12-weeks in length, the Company’s policy is to extend that quarter to the following Sunday. A 14th week is included in the fiscal year every five or six years to realign the Company’s fiscal quarters with calendar quarters. </span></div>The results reported in these interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire year.
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; loss contingencies; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite-lived assets (including intangible assets and goodwill), and inventory; the valuation and recognition of stock-based compensation, and the valuation of the debt derivative liability.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</span></div>
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents and trade accounts receivable are financial instruments that potentially subject the Company to concentrations of credit risk. Our Company policy limits, among other things, the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government. The Company maintains cash in U.S. bank accounts, the balance of which may at times exceed the federally insured limit.</span></div>
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7000000.0 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8300000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4100000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1700000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2000000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24522000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
23724000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16476000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13141000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18391000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
17735000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
7281000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
10349000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
458000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
384000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
41690000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
40841000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
4000000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
4900000 usd
CY2023Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64700000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64900000 usd
CY2023Q3 lfcr Registration Rights Agreement Penalty
RegistrationRightsAgreementPenalty
200000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2374325 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.88
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2100 shares
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.48
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
95800 shares
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
115000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
119850 shares
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.79
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2160775 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.89
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M28D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1506237 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.96
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y5M26D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1533000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
785000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11400000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12610000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6707000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1856000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4259000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10754000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30403000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30403000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29577000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29577000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.41
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.41
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.23
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.23
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.06
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.06
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.14
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88200 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0070
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0004
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
153816000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
150233000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
88830000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
84836000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
773000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
580000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
88057000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
84256000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
580000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
773000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
773000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
773000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
773000 usd
CY2023Q3 lfcr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
150144000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
153816000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64900000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64900000 usd
CY2023Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64700000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
64900000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-10000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
1047000 usd
us-gaap Restructuring Charges
RestructuringCharges
29946000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
2997000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-10000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
746000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
2241000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001005286-24-000110-index-headers.html Edgar Link pending
0001005286-24-000110-index.html Edgar Link pending
0001005286-24-000110.txt Edgar Link pending
0001005286-24-000110-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfcr-20230827.htm Edgar Link pending
lfcr-20230827.xsd Edgar Link pending
lfcr-20230827xexx311.htm Edgar Link pending
lfcr-20230827xexx312.htm Edgar Link pending
lfcr-20230827xexx321.htm Edgar Link pending
lfcr-20230827xexx322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
lfcr-20230827_cal.xml Edgar Link unprocessable
lfcr-20230827_def.xml Edgar Link unprocessable
lfcr-20230827_lab.xml Edgar Link unprocessable
lfcr-20230827_pre.xml Edgar Link unprocessable
lfcr-20230827_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable